• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Tech

Exclusive: Healthcare startup Vitals brings in new CEO

By
Laura Lorenzetti
Laura Lorenzetti
Down Arrow Button Icon
By
Laura Lorenzetti
Laura Lorenzetti
Down Arrow Button Icon
March 10, 2015, 9:25 AM ET
Courtesy of Vitals

Vitals, a health care startup that helps patients find doctors and medical facilities based on their patient ratings and price, is headed into a new stage of growth as it brings on a new chief executive to run the nearly seven-year-old company.

Heyward Donigan, previously CEO of ValueOptions, a company that specializes in mental wellbeing and recovery, will take over the top role from Vitals co-founder and chairman Mitch Rothschild. Vitals also announced that Jeffery Boyd, the chairman of the Priceline Group, will join as an advisor and board director.

“I was enamored at what we [at Vitals] could do to transform health care,” Donigan told Fortune. “Until the consumer is actually the one selecting the providers using good and insightful information, we won’t figure out how to adequately control costs.”

Vitals is one of many sites, including Castlight Health (CSLT) and ZocDoc, that help patients choose the best doctors or facilities in order to get better results. Vitals has built up a deep database of doctors and facilities across the country and is able to cross reference both patient reviews and price data to recommend the best option for a particular customer.

Vitals has grown exponentially, nearly quadrupling its revenue over the past three years, according to the company. Vitals has more than 10 million individual consumers and 26 million health plan participants visit the site each month to optimize their medical decisions. It has secured $45.3 million in funding to date from firms like Cardinal Partners, Athena and Greycroft Partners.

Donigan plans to expand Vitals reach through its website to give patients access to not only ratings on various doctors but also details on their specializations and volume of care, like how many shoulder surgeries an orthopedic surgeon has done. Volume is especially indicative of quality in situations where, essentially, practice makes perfect, such as surgeries.

Vitals new CEO Heyward Donigan.
Courtesy of Vitals

“It’s not just about cost but about experience, references, ratings and volume,” Donigan said. “We will have a number of filters by which members can make decisions against pieces of information that are indicative of quality. Very few people have attempted this, and it’s a game changer for health care.”

In her previous role at ValueOptions, Donigan grew the company to over $1 billion in revenue before it was acquired by Boston-based Beacon Health Strategies in December. Previous to ValueOptions, she helped craft Premera Blue Cross’ strategy that eventually provided customers access to the cost and quality of available practitioners.

By bringing Heyward and Boyd on board, Vitals is pushing into the next phase of growth that aims to engage users even more actively and further target health plans. Vitals bought smaller health care startup Compass in October that opens up the opportunity to expand Vitals’ reward system.

Compass’ technology could add a rewards component on top of Vitals search and recommendation capabilities. Once a patient chooses a less expensive but still high-quality option for a treatment, the service then calculates how much money is saved and shares a portion of that directly with the patient. The direct cash payback gives health care shoppers more incentive to log onto Vitals site and search for the best service.

Vitals will tap the expertise of newly hired advisor and board member Boyd to help expand this incentive. Boyd’s experience growing Priceline’s (PCLN) online travel marketplace into a $63 billion company provides the background and knowledge Vitals needs to expand its burgeoning e-commerce-like model.

About the Author
By Laura Lorenzetti
See full bioRight Arrow Button Icon

Latest in Tech

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

Latest in Tech

PoliticsDefense
Founder of $30 billion defense tech company Anduril embraces Trump’s threat to crack down: It’s ‘good to scare people sometimes’
By Marco Quiroz-GutierrezJanuary 8, 2026
4 hours ago
Jassy
Workplace CultureAmazon
Amazon demands proof of productivity from employees, asking for list of accomplishments
By Jake AngeloJanuary 8, 2026
7 hours ago
kappos
CommentaryEconomics
The Nobel Prize winners have a lesson for us all
By David J. KapposJanuary 8, 2026
7 hours ago
Dario Amodei sits in a white chair in front of a pink background and speaks animatedly.
AIEye on AI
AI is boosting productivity. Here’s why some workers feel a sense of loss
By Sharon GoldmanJanuary 8, 2026
8 hours ago
Mark DesJardine
CommentaryM&A
Warner Bros. Discovery’s board isn’t choosing a deal — it’s avoiding one
By Mark DesJardineJanuary 8, 2026
8 hours ago
Illustration of a human and robot hand holding a pharmacy and an AI symbol, respectively.
AImedicine
As Utah gives the AI power to prescribe some drugs, physicians warn of patient risks
By Beatrice NolanJanuary 8, 2026
8 hours ago

Most Popular

placeholder alt text
Law
Amazon is cutting checks to millions of customers as part of a $2.5 billion FTC settlement. Here's who qualifies and how to get paid
By Sydney LakeJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
AI layoffs are looking more and more like corporate fiction that's masking a darker reality, Oxford Economics suggests
By Nick LichtenbergJanuary 7, 2026
1 day ago
placeholder alt text
Economy
Mark Cuban on the $38 trillion national debt and the absurdity of U.S. healthcare: we wouldn't pay for potato chips like this
By Nick LichtenbergJanuary 6, 2026
2 days ago
placeholder alt text
Future of Work
'Employers are increasingly turning to degree and GPA' in hiring: Recruiters retreat from ‘talent is everywhere,’ double down on top colleges
By Jake AngeloJanuary 6, 2026
2 days ago
placeholder alt text
Success
Diary of a CEO founder says he hired someone with 'zero' work experience because she 'thanked the security guard by name' before the interview
By Emma BurleighJanuary 8, 2026
8 hours ago
placeholder alt text
Personal Finance
Current price of silver as of Wednesday, January 7, 2026
By Joseph HostetlerJanuary 7, 2026
1 day ago

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.